Quarterly report pursuant to Section 13 or 15(d)

9. RELATED PARTY TRANSACTIONS (Details)

v3.8.0.1
9. RELATED PARTY TRANSACTIONS (Details) - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Dec. 31, 2017
Sale and purchase of plasma      
Product revenue $ 2,328,291 $ 2,092,215  
Purchases 195,018 182,386  
License revenue 35,708 35,708  
Interest expense 225,000 $ 0  
Accounts receivable 726,409   $ 1,245,677
Prepaid expenses and other current assets 133,356   0
Accounts payable 94,256   139,939
Accrued expenses 380,607   314,820
Note payable, net of discount 14,850,048   14,842,396
Accrued interest 290,000   65,000
Deferred revenue $ 2,654,325   $ 2,690,033